Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Adoptive Immunotherapy with Cord Blood (CB) Grafts Targeting Shared Inherited Paternal Antigens (IPA) and/or Non-Inherited Maternal Antigens (NIMA) during Induction Treatment for High Risk Myeloid Malignancies: Safety and Preliminary Results

Usama Gergis, MD, Koen Van Besien, MD PhD, Emeline Masson Frenet, PhD, Tsiporah B. Shore, MD, Sebastian A. Mayer, MD, Adrienne A. Phillips, MD MPH, Jingmei Hsu, MD PhD, Gail J. Roboz, MD, Ellen K Ritchie, MD, Joseph Scandura, MDPhD, Sangmin Lee, MD, Pinkal Desai, MDMPH, Michael Samuel, MD, Jeffrey Ball, MD, Maria S. Albano, PhD, Rodica Ciubotariu, MD PhD, Ludy Dobrila, PhD, Cynthia Romeo, PhD, Andromachi Scaradavou, MD

Blood (2017) 130 (Supplement 1): 2627.

https://doi.org/10.1182/blood.V130.Suppl_1.2627.2627

Published: 2017

Journal Articles

A Phase II Study of a Novel Conditioning Regimen of Bendamustine and Melphalan Followed By Autologous Stem Cell Transplant for Patients with Multiple Myeloma

Alexandra Gomez-Arteaga, MD, Tomer M Mark, MDMSc, Danielle Guarneri, Paul J Christos, Dr.P.H., M.S., Usama Gergis, MD, June Greenberg, RN, Jingmei Hsu, MD PhD, Sebastian A. Mayer, MD, Ruben Niesvizky, MD, Roger Pearse, MD PhD, Adrienne A. Phillips, MD MPH, Adriana C. Rossi, MDMSc, Morton Coleman, MD, Koen Van Besien, MD PhD, Tsiporah B. Shore, MD

Blood (2017) 130 (Supplement 1): 4546.

https://doi.org/10.1182/blood.V130.Suppl_1.4546.4546

Published: 2017

Journal Articles

Novel Risk Factors for Epstein-Barr Virus (EBV) Reactivation and Post-Transplant Lymphoproliferative Disorder (PTLD) after Allogeneic Hematopoietic Stem Cell Transplant

Lizamarie Bachier Rodriguez, MD, Tsiporah B. Shore, MD, Usama Gergis, MD, Jingmei Hsu, MD PhD, Adrienne A. Phillips, MD MPH, Sebastian A. Mayer, MD, Hanna Rennert, PhD, Koen Van Besien, MD PhD

Blood (2017) 130 (Supplement 1): 1949.

https://doi.org/10.1182/blood.V130.Suppl_1.1949.1949

Published: 2017

Journal Articles

Kidney Dysfunction Post-Allogeneic Transplant: High Incidence of TMA and Kidney GvHD

Hannah K. Choe, MD, Vesh Srivatana, MD, Usama Gergis, MD, Tsiporah B. Shore, MD, Sebastian A. Mayer, MD, Jingmei Hsu, MD PhD, Adrienne A. Phillips, MD MPH, Surya V. Seshan, MD, Thangamani Muthukumar, MD, Koen Van Besien, MD PhD

Blood (2017) 130 (Supplement 1): 5500.

https://doi.org/10.1182/blood.V130.Suppl_1.5500.5500

Published: 2017

Journal Articles

Safe and Effective Implementation of a Red Blood Cell (RBC) Transfusion Hemoglobin (Hb) Threshold of 7 g/Dl on an Inpatient Stem Cell Transplant Unit: A Single Institution Experience

Melissa M. Cushing, MD, Ljiljana Vasovic, MD, Kathleen Kane, Usama Gergis, MD, Adriana C. Rossi, MDMSc, Adrienne A. Phillips, MD MPH, Yen-Michael S. Hsu, MD PhD, Craig Budzinski, Sebastian A. Mayer, MD, Jingmei Hsu, MD PhD, Sangmin Lee, MD, Tsiporah B. Shore, MD, Koen Van Besien, MD PhD, Ruchika Goel, MD MPH

Blood (2017) 130 (Supplement 1): 1131.

https://doi.org/10.1182/blood.V130.Suppl_1.1131.1131

Published: 2017

Journal Articles

Excellent Clinical Outcome for Relapsed and Refractory Lymphoma Patients with Haplo-Cord Allogeneic Stem Cell Transplantation

Jingmei Hsu, MD PhD, Andrew Artz, MD MS, Sebastian A. Mayer, MD, Michael R. Bishop, MD, Adrienne A. Phillips, MD MPH, Sonali M. Smith, MD, Usama Gergis, MD, Justin Kline, MD, Tsiporah B. Shore, MD, Koen van Besien, MD

Blood (2016) 128 (22): 3496.

https://doi.org/10.1182/blood.V128.22.3496.3496

Published: 2016

Journal Articles

ASXL1 Mutations in AML: Molecular Biomarker for Secondary AML?

Jingmei Hsu, MD PhD, Anita J. Kumar, MDMS, Martin P. Carroll, MD, Noelle V. Frey, MDMS, Nirav N. Shah, MD, Zhao Jianhua, PhD, Elizabeth O. Hexner, MD, Alison W. Loren, MD, James K. Mangan, MDPhD, Alexander E. Perl, MD, David Porter, MD, Jennifer Morrissette, PhD, Selina M. Luger, MD

Blood (2014) 124 (21): 2343.

https://doi.org/10.1182/blood.V124.21.2343.2343

Published: 2014

Journal Articles

Chromatin Remodeling Enzyme CHD7 Negatively Regulate Hematopoietic Stem Cell Function

Jingmei Hsu, MD, PhD, Hsuan-Ting Huang, Ph.D, Chung-Tsai Lee, Shuqian Yu, MS, Leonard I. Zon, MD, Nancy A. Speck, PhD

Blood (2013) 122 (21): 2413.

https://doi.org/10.1182/blood.V122.21.2413.2413

Published: 2013

Journal Articles

CHD7 Negatively Regulates Hematopoietic Stem Cell Potency

Jingmei Hsu, MD, PhD, Hsuan-Ting Huang, Chung-Tsai Lee, Shuqian Yu, MS, Scott Gerber, PhD, Leonard I. Zon, MD, Nancy A. Speck, PhD

Blood (2012) 120 (21): 850.

https://doi.org/10.1182/blood.V120.21.850.850

Published: 2012

Journal Articles

Runx1-Cbfb Interacts with CHD7, a Chromatin Modifying Enzyme with a Potential Role in Hematopoiesis

Jingmei Hsu, MD, PhD, Chung-Tsai Lee, Scott Gerber, PhD, Shuqian Yu, MS, Nancy A. Speck, PhD

Blood (2011) 118 (21): 1300.

https://doi.org/10.1182/blood.V118.21.1300.1300

Published: 2011

NARROW

Adoptive Immunotherapy with Cord Blood (CB) Grafts Targeting Shared Inherited Paternal Antigens (IPA) and/or Non-Inherited Maternal Antigens (NIMA) during Induction Treatment for High Risk Myeloid Malignancies: Safety and Preliminary Results

A Phase II Study of a Novel Conditioning Regimen of Bendamustine and Melphalan Followed By Autologous Stem Cell Transplant for Patients with Multiple Myeloma

Novel Risk Factors for Epstein-Barr Virus (EBV) Reactivation and Post-Transplant Lymphoproliferative Disorder (PTLD) after Allogeneic Hematopoietic Stem Cell Transplant

Kidney Dysfunction Post-Allogeneic Transplant: High Incidence of TMA and Kidney GvHD

Safe and Effective Implementation of a Red Blood Cell (RBC) Transfusion Hemoglobin (Hb) Threshold of 7 g/Dl on an Inpatient Stem Cell Transplant Unit: A Single Institution Experience

Excellent Clinical Outcome for Relapsed and Refractory Lymphoma Patients with Haplo-Cord Allogeneic Stem Cell Transplantation

ASXL1 Mutations in AML: Molecular Biomarker for Secondary AML?

Chromatin Remodeling Enzyme CHD7 Negatively Regulate Hematopoietic Stem Cell Function

CHD7 Negatively Regulates Hematopoietic Stem Cell Potency

Runx1-Cbfb Interacts with CHD7, a Chromatin Modifying Enzyme with a Potential Role in Hematopoiesis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only